Terms: = Ovarian cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx AND Prognosis
5 results:
1. HERC4 modulates ovarian cancer cell proliferation by regulating smo-elicited hedgehog signaling.
Zhu Q; Yang X; Lv Y
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130557. PubMed ID: 38181892
[TBL] [Abstract] [Full Text] [Related]
2. Triptolide inhibits epithelial ovarian tumor growth by blocking the hedgehog/Gli pathway.
Hu L; Gao M; Jiang H; Zhuang L; Jiang Y; Xie S; Zhang H; Wang Q; Chen Q
Aging (Albany NY); 2023 Oct; 15(20):11131-11151. PubMed ID: 37851362
[TBL] [Abstract] [Full Text] [Related]
3. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
[TBL] [Abstract] [Full Text] [Related]
4. Survival of Patients With Mucinous ovarian Carcinoma and ovarian Metastases: A Population-Based cancer Registry Study.
Simons M; Ezendam N; Bulten J; Nagtegaal I; Massuger L
Int J Gynecol Cancer; 2015 Sep; 25(7):1208-15. PubMed ID: 25978291
[TBL] [Abstract] [Full Text] [Related]
5. Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis.
Chen X; Horiuchi A; Kikuchi N; Osada R; Yoshida J; Shiozawa T; Konishi I
Cancer Sci; 2007 Jan; 98(1):68-76. PubMed ID: 17083567
[TBL] [Abstract] [Full Text] [Related]